An economic evaluation of laparoscopic ovarian diathermy versus gonadotrophin therapy for women with clomiphene citrate-resistant polycystic ovarian syndrome

Current Opinion in Obstetrics and Gynecology

Volumn 17, Issue 4, 2005, Pages 347-353

  Farquhar, Cynthia M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Economic analysis; Gonadotrophins; Laparoscopic surgery; Polycystic ovarian syndrome

Indexed keywords

CLOMIFENE CITRATE; GONADOTROPIN;

COST EFFECTIVENESS ANALYSIS; DIATHERMY; ECONOMIC EVALUATION; HEALTH CARE; HUMAN; LAPAROSCOPY; NETHERLANDS; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 22944448015     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000175351.18308.3a     Document Type: Review

References (53)

1. Stein IF, Leventhal NL. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynaecol 1935; 29:181-181.
2. Goldzieher JW, Green JA. The polycystic ovary: clinical and histological features. J Clin Endocrinol Metab 1962; 22:325-338.
3. Kistner RW. Peri-tubal and peri-ovarian adhesions subsequent to wedge resection of the ovaries. Fertil Steril 1969; 20:35-42.
4. Buttram VC, Vaquwero C. Post-ovarian wedge resection adhesive disease. Fertil Steril 1975; 26:874-876.
5. Toaff R, Toaff ME, Peyser MR. Infertility following wedge resection of the ovaries. Am J Obstet Gynecol 1976; 124:92-96.
6. Gemzell C, Carlborl, Johansson ED, et al. Treatment of primary amenorrhoea with human pituitary and chorionic gonadotrophins. J Obstet Gynaecol Br Commonw 1970; 77:58-64.
7. Lunenfeld B, Menzi A, Volet B. Effetti clinici della gonadotropina umana della post-menopausa [Clinical effects of a human postmenopausal gonadotropin]. Rass Clin Terap 1960; 59:213-216.
8. Kistner RW. Induction of ovulation with clomiphene citrate (clomid). Obstet Gynecol Surv 1965; 20:873-900.
9. Connaughton JF, Garcia C-R, Wallach EE. Induction of ovulation with cisclomiphene and a placebo. Obstet Gynecol 1974; 43:697-701.
10. Cudmore DW, Tupper WRC. Induction of ovulation with clomiphene citrate. Fertil Steril 1966; 17:363-373.
11. Garcia C-R, Freeman ER, Rickels K, et al. Behavioral and emotional factors and treatment responses in a study of anovulatory infertile women. Fertil Steril 1985; 44:478-483.
12. Johnson JE, Cohen MR, Goldfarb AF, et al. The efficacy of clomiphene citrate for induction of ovulation. Int J Fertil 1966; 11:265-270.
13. Hammond MG, Halme JK, Talbert LM. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obstet Gynecol 1983; 62:196-202.
14. The ESHRE Capri Workshop. Female infertility: treatment options for complicated cases. Hum Reprod 1997; 12:1191-1196.
15. Bayram N, van Wely M, van der Veen F. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome [Cochrane review]. The Cochrane Library, Issue 2. Chichester, UK: John Wiley & Sons; 2005. A Cochrane review on gonadotrophins for women with PCOS.
16. Forman RG, Frydman R, Egan D, et al. Severe ovarian hyperstimulation syndrome using agonists of gonadotrophin releasing hormone for in vitro fertilization: a European series and a proposal for prevention. Fertil Steril 1990; 53:502-509.
17. Wada I, Matson PL, Troup SA, et al. Ovarian hyperstimulation syndrome in GnRH-a/hMG cycles for IVF and GIFT. J Obstet Gynaecol 1990; 11:88-89.
18. MacDougall MJ, Tan SL, Jacobs HS. In vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod 1992; 7:579-600.
19. Medical Research International, Society for Assisted Reproductive Technology (SART), The American Fertility Society. In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1990 results from the IVF-ET registry. Fertil Steril 1992; 57:15-24.
20. Fahri J, Soule S, Jacobs HS. Effect of laparoscopic ovarian electrocautery on ovarian response and outcome of treatment with gonadotrophins in clomiphene-resistant patients with polycystic ovary syndrome. Fertil Sertil 1995; 64:930-935.
21. Homburg R, Armar NA, Eshel A, et al. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 1988; 297:1024-1026.
22. Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinising hormone, infertility and miscarriage. Lancet 1990; 336:1141-1144.
23. Farquhar C, Vandekerckhove P, Lilford R. Laparoscopic 'drilling' by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome [Cochrane review]. The Cochrane Library, Issue 2. Chichester, UK: John Wiley & Sons; 2005. A Cochrane review of four RCTs with live birth and ongoing pregnancy rate did not find evidence of a difference between ovarian drilling and gonadotrophins, with the exception of multiple pregnancy which was reduced in women with ovarian drilling.
24. Nugent D, Vandekerckhove P, Hughes E, et al. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome [Cochrane review]. The Cochrane Library, Issue 4. Chichester, UK: John Wiley & Sons; 2003.
25. Levene MI, Wild J, Steer P. Higher multiple births and the modern management of infertility in Britain. Br J Obstet Gynaecol 1992; 99:607-613.
26. Cohen BM. Laser laparoscopy for polycystic ovaries. Fertil Steril 1989; 52:167-168.
27. Gjoanness H. Ovarian electrocautery in the treatment of women with PCOS. Acta Obstet Gynaecol Scand 1994; 73:407-412.
28. Katz M, Carr PJ, Cohen BM, et al. Hormonal effects of wedge resection of polycystic ovaries. Obstet Gynecol 1978; 23:93-99.
29. Greenblatt E, Casper RF. Endocrine changes after laparoscopic ovarian cautery in polycystic ovarian syndrome. Am J Obstet Gynecol 1987; 156:279-285.
30. Armar N, McGarrigle H, Honour J, et al. Laparoscopic ovarian in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcomes. Fertil Steril 1990; 53:45-49.
31. Liguori G, Tolino A, Moccia G, et al. Laparoscopic ovarian treatment in infertile patients with polycystic ovarian syndrome (PCOS): endocrine changes and clinical outcome. Gynecol Endocrinol 1996; 10:257-264.
32. Gjonnaess H. Late endocrine effects of ovarian electrocautery in women with polycystic ovary syndrome. Fertil Steril 1998; 69:697-701.
33. Rossmanith WG, Keckstein J, Spatzier K,et al. The impact of ovarian laser surgery on the gonadotrophin secretion in women with polycystic ovarian disease. Clin Endocrinol (Oxf) 1991; 34:23-30.
34. Sakata M, Tasaka K, Kurachi H, et al. Changes of bioactive luteinizing hormone after laparoscopic ovarian cautery in patients with polycystic ovarian syndrome. Fertil Steril 1990; 53:10-13.
35. Alborzi S, Khodaee R, Parsanejad ME. Ovarian size and response to laparoscopic ovarian electro-cauterization in polycystic ovarian disease. Int J Gynecol Obstet 2001; 74:269-274.
36. Amer SA, Banu Z, Li TC, Cooke ID. Long-term follow-up of patients with polycystic ovary syndrome after laparoscopic ovarian drilling: endocrine and ultrasonic outcomes. Hum Reprod 2002; 17:851-857.
37. Armar NA, McGarrigle HH, Honour J, et al. Laparoscopic ovarian in the management of an ovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome. Fertil Steril 1990; 53:5-9.
38. Donesky BW, Adashi EY. Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy. Fertil Steril 1995; 63:439-463.
39. Abdel Gadir A, Mowafi R, Alnaser H, et al. Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease. Clin Endocrinol 1990; 33:585-592.
40. Abdel Gadir A, Alnaser H, Mowafi R, et al. The response of patients with polycystic ovarian disease to human menopausal gonadotropin therapy after ovarian electrocautery or a luteinizing hormone-releasing hormone agonist. Fertil Steril 1992; 57:309-313.
41. Bayram N, van Wely M, Kaaijk EM, et al. Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial. BMJ 2004; 328:192-195. The largest RCT of laparoscopic ovarian surgery (with a proportion undergoing ovulation induction) versus gonadotrophins. The outcomes were live birth, multiple pregnancy, quality of life and cost.
42. Farquhar CM, Williamson K, Gudex G, et al. A randomised controlled trial of laparoscopic ovarian diathermy versus gonadotrophin therapy for women with clomiphene resistant polycystic ovarian syndrome. Fertil Steril 2002; 78:401-411.
43. Lazovic G, Milacic D, Terzic M, et al. Medicaments or surgical therapy of PCOS [abstract]. Fertil Steril 1998; 70:472.
44. Vegetti W, Ragni G, Baroni E, et al. Laparoscopic ovarian versus low-dose pure FSH in anoulatory clomiphene-resistant patients with polycystic ovarian syndrome: randomized propective study [abstract]. Hum Reprod 1998; 13:120.
45. Kovacs GT, Clarke S, Burger HG, et al. Surgical or medical treatment of polycystic ovary syndrome: a cost-benefit analysis. Gynecol Endocrinol 2002; 16:53-55.
46. Farquhar CM, Williamson K, Brown PM, et al. An economic evaluation of laparoscopic ovarian diathermy versus gonadotrophin therapy for women with clomiphene citrate resistant polycystic ovary syndrome. Hum Reprod 2004; 19:1110-1115. Economic analysis of a RCT showing a cost difference in favour of laparoscopic surgery.
47. van Wely M, Bayram N, Bossunyt PMM, et al. An economic comparison of a laparoscopic electrocoagulation strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome. Hum Reprod 2004; 19:1741-1745. Economic analysis of a RCT showing a cost difference in favour of laparoscopic surgery.
48. van Wely M, Bayram N, Bossunyt PMM, et al. Laparoscopic electrocautery of the ovaries of recombinant FSH in clomiphene citrate-resistant polycystic ovary syndrome: impact on women's health-related quality of life. Hum Reprod 2004; 19:2244-2250. A RCT comparing laparoscopic ovarian surgery (with a proportion undergoing ovulation induction) with gonadotrophins reporting quality of life.
49. van Wely M, Bayram N, van der Veen F, Bossuyt PMM. Predictors for treatment failure after laparoscopic electrocautery of the ovaries in women with clomiphene citrate resistant polycystic ovary syndrome. Hum Reprod 2005; 7 January 2005 [Epub ahead of print]. Analysis of predictors of success from 83 women in a RCT who underwent LOD.
50. Wolner-Hanssen P, Rydhstroem H. Cost-effectiveness analysis of in-vitro fertilization: estimated costs per successful pregnancy after transfer of one or two embryos. Hum Reprod 1998; 13:88-94.
51. Mugford M, Henderson J. Multiple births. In: Ward HR, Whittle M, editors. Resource implications of multiple births. London, UK: RCOG; 1995. pp. 344-345.
52. Bhattacharya S, Templeton A. What is the most relevant standard of success in assisted reproduction? Redefining success in the context of elective single embryo transfer: evidence, intuition and financial reality. Hum Reprod 2004; 19:1939-1942. Narrative review of embryo transfer supporting concept of singleton birth being best outcome.
53. Legro RS, Myers E. Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome? Hum Reprod 2004; 19:1697-1704. This paper on methodology described the problems with outcomes in fertility trials and places an emphasis on live birth as an outcome because of the increased likelihood of multiple pregnancies.